Nonsurgical Periodontal Therapy Impacts Salivary and Serum Bone Turnover Markers in Periodontitis

Faraha Javed; Afaf Zia; Asad Ullah Khan; Afsha Bey; Seema Hakim; Hira Ateeq; Faiz Noor Khan Yusufi; Nasir Salati

doi:10.1055/s-0045-1802332

European Dental Research and Biomaterials Journal, Inhaltsverzeichnis

CC BY-NC-ND 4.0 · European Dental Research and Biomaterials Journal 2024; 05(01/02): 008-017
DOI: 10.1055/s-0045-1802332

Original Article

Nonsurgical Periodontal Therapy Impacts Salivary and Serum Bone Turnover Markers in Periodontitis

Faraha Javed

¹Department of Pediatric and Preventive Dentistry, Dr. Ziauddin Ahmed Dental College (DRZADC), Aligarh Muslim University (AMU), Aligarh, Uttar Pradesh, India

,

Afaf Zia

²Department of Periodontics and Community Dentistry, DRZADC, Aligarh Muslim University, Aligarh, Uttar Pradesh, India

,

Asad Ullah Khan

³Interdisciplinary Biotechnology Unit, Aligarh Muslim University, Aligarh, Uttar Pradesh, India

,

Afsha Bey

²Department of Periodontics and Community Dentistry, DRZADC, Aligarh Muslim University, Aligarh, Uttar Pradesh, India

,

Seema Hakim

⁴Department of Obstetrics and Gynecology, Jawaharlal Nehru Medical College and Hospital (JNMCH), Aligarh Muslim University, Aligarh, Uttar Pradesh, India

,

Hira Ateeq

⁵Department of Biochemistry, Aligarh Muslim University, Aligarh, Uttar Pradesh, India

,

Faiz Noor Khan Yusufi

⁶Department of Statistics and Operations, Aligarh Muslim University, Aligarh, Uttar Pradesh, India

,

Nasir Salati

⁷Department of Oral & Dental Pathology & Microbiology, DRZADC, Aligarh Muslim University, Aligarh, Uttar Pradesh, India

› Institutsangaben

Abstract

Objectives To assess nonsurgical periodontal therapy's (NSPT's) effect on bone turnover markers (BTMs) in periodontitis patients and compare the efficacy of saliva and serum samples in evaluating periodontal health.

Materials and Methods Sixty-five females aged 18 to 45 years were divided into control (n = 20) and test (n = 45) groups. Periodontitis patients underwent NSPT. Full mouth clinical periodontal parameters and salivary/serum BTMs (C-terminal telopeptides of type I collagen [CTX], bone-specific alkaline phosphatase [BALP], osteoprotegerin [OPG]) were recorded at baseline, 3 weeks, and 3 months post-NSPT.

Statistical Analysis The study measured test group readings at three points: baseline, 3 weeks, and 3 months after NSPT. Normality was assessed using the Shapiro–Wilk test, showing a nonnormal distribution (p < 0.05). To test for significance among groups, the Kruskal–Wallis test was applied. The Friedman test, along with pairwise comparisons, was used to compare test group readings across time points. A 5% significance level was maintained. Pearson correlation measured relationships between the control and test groups and within the test group at different intervals. Multiple linear regression was conducted across time points, with plaque index (PI), gingival index (GI), probing pocket depth (PPD), and clinical attachment level (CAL) set as dependent variables, and salivary and serum BALP, CTX, and OPG as independent variables. All analyses were performed using IBM SPSS version 20 and R version 3.5.2.

Results Following NSPT, significant changes were observed in all measured salivary/serum BTMs except serum BALP (p > 0.05). No significant differences noted between BTM measurements taken at 3 weeks and 3 months post-NSPT (p > 0.05). Correlations between BTMs and periodontal measurements were weak to moderate after NSPT. A multiple linear regression model explained 46.7% of the total variability for PI, 50.1% for PPD, 54.1% for CAL, and 29.3% for GI signifying association with BTMs among groups.

Conclusion NSPT results in significant changes in salivary/serum BTMs. Following NSPT, BTMs show associations with periodontal parameters, highlighting modulation of host responses. BTMs in salivary/serum samples effectively reflected periodontal health and disease status and improvements after therapy.

Keywords

bone turnover markers - periodontal disease - nonsurgical periodontal therapy - saliva - serum

Volltext

Referenzen

References
1 Faddy MJ, Cullinan MP, Palmer JE, Westerman B, Seymour GJ. Ante-dependence modeling in a longitudinal study of periodontal disease: the effect of age, gender, and smoking status. J Periodontol 2000; 71 (03) 454-459
2 Schulze-Späte U, Turner R, Wang Y. et al. Relationship of bone metabolism biomarkers and periodontal disease: the Osteoporotic Fractures in Men (MrOS) study. J Clin Endocrinol Metab 2015; 100 (06) 2425-2433
3 Betsy J, Ahmed JM, Mohasin AK, Mohammed A, Nabeeh A A. Diagnostic accuracy of salivary biomarkers of bone turnover in identifying patients with periodontitis in a Saudi Arabian population. J Dent Sci 2019; 14 (03) 269-276
4 Papapanou PN, Susin C. Periodontitis epidemiology: is periodontitis under-recognized, over-diagnosed, or both?. Periodontol 2000 2017; 75 (01) 45-51
5 Shazam H, Shaikh F, Hussain Z. Bone turnover markers in chronic periodontitis: a literature review. Cureus 2020; 12 (01) e6699
6 Armitage GC. Periodontal diagnoses and classification of periodontal diseases. Periodontol 2000 2004; 34: 9-21
7 Janakiram C, Mehta A, Venkitachalam R. Prevalence of periodontal disease among adults in India: a systematic review and meta-analysis. J Oral Biol Craniofac Res 2020; 10 (04) 800-806
8 Martínez-García M, Hernández-Lemus E. Periodontal inflammation and systemic diseases: an overview. Front Physiol 2021; 12: 709438
9 Gursoy UK, Liukkonen J, Jula A. et al. Associations between salivary bone metabolism markers and periodontal breakdown. J Periodontol 2016; 87 (04) 367-375
10 Al-Sabbagh M, Alladah A, Lin Y. et al. Bone remodeling-associated salivary biomarker MIP-1α distinguishes periodontal disease from health. J Periodontal Res 2012; 47 (03) 389-395
11 Miller CS, King Jr CP, Langub MC, Kryscio RJ, Thomas MV. Salivary biomarkers of existing periodontal disease: a cross-sectional study. J Am Dent Assoc 2006; 137 (03) 322-329
12 Buduneli N, Biyikoğlu B, Sherrabeh S, Lappin DF. Saliva concentrations of RANKL and osteoprotegerin in smoker versus non-smoker chronic periodontitis patients. J Clin Periodontol 2008; 35 (10) 846-852
13 Tobón-Arroyave SI, Isaza-Guzmán DM, Restrepo-Cadavid EM, Zapata-Molina SM, Martínez-Pabón MC. Association of salivary levels of the bone remodelling regulators sRANKL and OPG with periodontal clinical status. J Clin Periodontol 2012; 39 (12) 1132-1140
14 Frodge BD, Ebersole JL, Kryscio RJ, Thomas MV, Miller CS. Bone remodeling biomarkers of periodontal disease in saliva. J Periodontol 2008; 79 (10) 1913-1919
15 Yoshihara A, Deguchi T, Hanada N, Miyazaki H. Relation of bone turnover markers to periodontal disease and jaw bone morphology in elderly Japanese subjects. Oral Dis 2009; 15 (02) 176-181
16 Gibert P, Tramini P, Sieso V, Piva MT. Alkaline phosphatase isozyme activity in serum from patients with chronic periodontitis. J Periodontal Res 2003; 38 (04) 362-365
17 Sexton WM, Lin Y, Kryscio RJ, Dawson III DR, Ebersole JL, Miller CS. Salivary biomarkers of periodontal disease in response to treatment. J Clin Periodontol 2011; 38 (05) 434-441
18 Zia A, Hakim S, Khan AU. et al. Bone markers and bone mineral density associates with periodontitis in females with poly-cystic ovarian syndrome. J Bone Miner Metab 2022; 40 (03) 487-497
19 Caton JG, Armitage G, Berglundh T. et al. A new classification scheme for periodontal and peri-implant diseases and conditions - introduction and key changes from the 1999 classification. J Periodontol 2018; 89 (Suppl. 01) S1-S8
20 Shanbhag S, Dahiya M, Croucher R. The impact of periodontal therapy on oral health-related quality of life in adults: a systematic review. J Clin Periodontol 2012; 39 (08) 725-735
21 Kardeşler L, Buduneli N, Cetinkalp S, Kinane DF. Adipokines and inflammatory mediators after initial periodontal treatment in patients with type 2 diabetes and chronic periodontitis. J Periodontol 2010; 81 (01) 24-33
22 Greenblatt MB, Tsai JN, Wein MN. Bone turnover markers in the diagnosis and monitoring of metabolic bone disease. Clin Chem 2017; 63 (02) 464-474
23 Lian JB, Stein GS, Aubin JE. Bone formation: maturation and functional activities ofosteoblast lineage cells. In: Favus MJ. ed. Primer on the Metabolic Bone Diseases and Disorder of Mineral Metabolism. 5th edn. Washington, DC: American Society for Boneand Mineral Research; 2003: 13-28
24 Mogi M, Otogoto J, Ota N, Togari A. Differential expression of RANKL and osteoprotegerin in gingival crevicular fluid of patients with periodontitis. J Dent Res 2004; 83 (02) 166-169
25 Pellegrini GG, Gonzales CM, Somoza JC, Friedman SM, Zeni SN. Correlation between salivary and serum markers of bone turnover in osteopenic rats. J Periodontol 2008; 79 (01) 158-165
26 Joseph B, Javali MA, Khader MA, AlQahtani SM, Amanullah M. Salivary osteocalcin as potential diagnostic marker of periodontal bone destruction among smokers. Biomolecules 2020; 10 (03) 380
27 Vasikaran S, Cooper C, Eastell R. et al. International Osteoporosis Foundation and International Federation of Clinical Chemistry and Laboratory Medicine position on bone marker standards in osteoporosis. Clin Chem Lab Med 2011; 49 (08) 1271-1274
28 Garnero P, Ferreras M, Karsdal MA. et al. The type I collagen fragments ICTP and CTX reveal distinct enzymatic pathways of bone collagen degradation. J Bone Miner Res 2003; 18 (05) 859-867
29 Reckelkamm SL, Hannemann A, Kocher T. et al. Association between bone turnover markers and periodontitis: a population-based cross-sectional study. J Clin Periodontol 2022; 49 (07) 633-641
30 Asquino N, Vigil G, Prado VP, Rossy LAB, Molina RB. Bone resorption in periodontal disease: the role of RANK, RANKL and OPG. A literature review. Odontoestomatología 2022; 24 (40) e316
31 Bostanci N, Ilgenli T, Emingil G. et al. Differential expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin mRNA in periodontal diseases. J Periodontal Res 2007; 42 (04) 287-293
32 Lu HK, Chen YL, Chang HC, Li CL, Kuo MYP. Identification of the osteoprotegerin/receptor activator of nuclear factor-kappa B ligand system in gingival crevicular fluid and tissue of patients with chronic periodontitis. J Periodontal Res 2006; 41 (04) 354-360
33 Szulc P, Hofbauer LC, Heufelder AE, Roth S, Delmas PD. Osteoprotegerin serum levels in men: correlation with age, estrogen, and testosterone status. J Clin Endocrinol Metab 2001; 86 (07) 3162-3165
34 Yang L, Grey V. Pediatric reference intervals for bone markers. Clin Biochem 2006; 39 (06) 561-568
35 Belibasakis GN, Bostanci N. The RANKL-OPG system in clinical periodontology. J Clin Periodontol 2012; 39 (03) 239-248
36 Ramseier CA, Kinney JS, Herr AE. et al. Identification of pathogen and host-response markers correlated with periodontal disease. J Periodontol 2009; 80 (03) 436-446
37 Costa PP, Trevisan GL, Macedo GO. et al. Salivary interleukin-6, matrix metalloproteinase-8, and osteoprotegerin in patients with periodontitis and diabetes. J Periodontol 2010; 81 (03) 384-391
38 Aldahlawi S. Evaluation of serum RANKL and OPG concentrations in patients with periodontitis in Saudi Arabia. IJPRAS 2019; 8 (01) 45-51
39 Browner WS, Lui LY, Cummings SR. Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women. J Clin Endocrinol Metab 2001; 86 (02) 631-637
40 Kinney JS, Morelli T, Braun T. et al. Saliva/pathogen biomarker signatures and periodontal disease progression. J Dent Res 2011; 90 (06) 752-758
41 Ozçaka O, Nalbantsoy A, Buduneli N. Salivary osteocalcin levels are decreased in smoker chronic periodontitis patients. Oral Dis 2011; 17 (02) 200-205
42 Zekeridou A, Mombelli A, Cancela J, Courvoisier D, Giannopoulou C. Systemic inflammatory burden and local inflammation in periodontitis: what is the link between inflammatory biomarkers in serum and gingival crevicular fluid?. Clin Exp Dent Res 2019; 5 (02) 128-135